TransMedics Group Inc
Company Profile
Business description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Contact
200 Minuteman Road
AndoverMA01810
USAT: +1 978 552-0900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
728
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,741.90 | 26.70 | -0.30% |
CAC 40 | 7,804.87 | 14.60 | 0.19% |
DAX 40 | 24,304.46 | 19.12 | -0.08% |
Dow JONES (US) | 42,762.87 | 443.13 | 1.05% |
FTSE 100 | 8,837.91 | 26.87 | 0.30% |
HKSE | 24,092.21 | 299.67 | 1.26% |
NASDAQ | 19,529.95 | 231.51 | 1.20% |
Nikkei 225 | 38,137.09 | 395.48 | 1.05% |
NZX 50 Index | 12,529.42 | 34.06 | -0.27% |
S&P 500 | 6,000.36 | 61.06 | 1.03% |
S&P/ASX 200 | 8,515.70 | 23.20 | -0.27% |
SSE Composite Index | 3,396.59 | 11.24 | 0.33% |